SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma shines on incorporating Wholly Owned Step-down Subsidiary in Russia

27 Jul 2023 Evaluate

Aurobindo Pharma is currently trading at Rs. 826.00, up by 37.15 points or 4.71% from its previous closing of Rs. 788.85 on the BSE.

The scrip opened at Rs. 798.00 and has touched a high and low of Rs. 829.50 and Rs. 792.10 respectively. So far 27014 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 829.50 on 27-Jul-2023 and a 52 week low of Rs. 397.30 on 03-Feb-2023.

Last one week high and low of the scrip stood at Rs. 829.50 and Rs. 770.80 respectively. The current market cap of the company is Rs. 46221.77 crore.

The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 39.86% and 8.31% respectively.

Aurobindo Pharma has incorporated a Wholly Owned Step-down Subsidiary namely ‘Auro Pharma LLC’ in Russia, in order to pursue pharma business operations in Russia. The company proposes to make an initial investment of around $10 million.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1382.50 -3.15 (-0.23%)
20-Apr-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.05
Dr. Reddys Lab 1237.50
Cipla 1239.40
Zydus Lifesciences 942.20
Lupin 2327.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×